SCHEDULE: Citadel Entities Report Stake in Core Scientific

Several Citadel-affiliated entities have reported beneficial ownership of Core Scientific, Inc. common stock, collectively holding approximately 6.5% of the outstanding shares.

Summary

• Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC, and Kenneth Griffin (collectively, the 'Reporting Persons') have jointly filed a Schedule 13G.
• The filing reports beneficial ownership of Core Scientific, Inc. common stock.
• The total beneficial ownership reported by the Reporting Persons is 20,850,479 shares, representing approximately 6.5% of the outstanding shares.
• This percentage is based on 321,341,430 shares outstanding as of July 23, 2026, plus 989 shares issuable upon conversion of certain warrants held by reporting persons or their affiliates.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports changes in beneficial ownership without providing new operational or financial performance data.

Positives

• The filing indicates significant investment interest from major financial entities, which can sometimes be interpreted as a positive signal regarding the company's potential.
• The reporting persons hold shared voting and dispositive power, indicating a coordinated approach to their investment.

Negatives

• The filing does not contain any financial performance data or operational updates, making it impossible to assess the company's current health or future prospects based on this document alone.
• The reporting persons have no sole voting or sole dispositive power, indicating that decisions are made collectively or with other parties.

Risks

• Concentration of ownership by a few entities could potentially influence corporate actions or strategic decisions.
• The filing does not provide details on the specific investment strategy or intentions of the reporting persons, leaving room for speculation about future actions.

Future Outlook

This filing is a Schedule 13G, which reports beneficial ownership and does not contain forward-looking statements or company guidance.

Industry Context

StockSavvy.ai notes that large institutional filings like this Schedule 13G are common in the technology and cryptocurrency mining sectors, reflecting significant capital flows and strategic positioning by major investment firms.

Comparison to Industry Standards

• The filing does not provide performance metrics to compare against industry standards.
• The ownership percentage of 6.5% by Citadel entities is a substantial stake, but within the typical range for institutional investors in publicly traded companies, not necessarily deviating from industry norms for significant holdings.

Stakeholder Impact

• Shareholders: The increased institutional interest may signal confidence in the company's long-term prospects, potentially influencing share price, but also indicates a significant portion of shares are held by entities with shared voting power.
• Creditors: No direct impact mentioned, but significant ownership changes can indirectly affect a company's financial stability and creditworthiness.
• Employees: No direct impact mentioned.

Next Steps

• The Reporting Persons will continue to monitor their investment in Core Scientific, Inc.

Key Dates

Keywords

Core Scientific, Citadel Securities, Schedule 13G, Beneficial Ownership, Common Stock, Investment, Delaware, Kenneth Griffin